gimatecan

gimatecan · Novartis

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for gimatecan, covering 2009-06-03 to 2021-04-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer [Phase 2]